Versant Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.8K Buy
+1,424
New +$10.8K ﹤0.01% 1863
2024
Q4
Sell
-87
Closed -$901 2391
2024
Q3
$901 Buy
87
+36
+71% +$373 ﹤0.01% 1773
2024
Q2
$661 Sell
51
-18
-26% -$233 ﹤0.01% 1741
2024
Q1
$1.21K Hold
69
﹤0.01% 1493
2023
Q4
$649 Buy
69
+20
+41% +$188 ﹤0.01% 1621
2023
Q3
$547 Sell
49
-514
-91% -$5.74K ﹤0.01% 1673
2023
Q2
$12K Buy
563
+458
+436% +$9.8K ﹤0.01% 703
2023
Q1
$4.23K Sell
105
-7
-6% -$282 ﹤0.01% 1004
2022
Q4
$5.21K Sell
112
-31
-22% -$1.44K ﹤0.01% 881
2022
Q3
$7K Buy
143
+39
+38% +$1.91K ﹤0.01% 743
2022
Q2
$5K Hold
104
﹤0.01% 850
2022
Q1
$7K Sell
104
-41
-28% -$2.76K ﹤0.01% 777
2021
Q4
$11K Hold
145
﹤0.01% 687
2021
Q3
$8K Buy
145
+84
+138% +$4.63K ﹤0.01% 751
2021
Q2
$3K Buy
61
+4
+7% +$197 ﹤0.01% 1033
2021
Q1
$3K Buy
+57
New +$3K ﹤0.01% 1145
2020
Q2
Sell
-23
Closed -$1K 1362
2020
Q1
$1K Hold
23
﹤0.01% 1128
2019
Q4
$1K Hold
23
﹤0.01% 1221
2019
Q3
$1K Hold
23
﹤0.01% 1240
2019
Q2
$1K Sell
23
-41
-64% -$1.78K ﹤0.01% 1271
2019
Q1
$6K Sell
64
-19
-23% -$1.78K ﹤0.01% 1045
2018
Q4
$5K Hold
83
﹤0.01% 1016
2018
Q3
$7K Hold
83
﹤0.01% 982
2018
Q2
$9K Hold
83
﹤0.01% 916
2018
Q1
$6K Hold
83
﹤0.01% 1019
2017
Q4
$4K Hold
83
﹤0.01% 1166
2017
Q3
$3K Sell
83
-76
-48% -$2.75K ﹤0.01% 1157
2017
Q2
$5K Sell
159
-11
-6% -$346 ﹤0.01% 1046
2017
Q1
$5K Sell
170
-3
-2% -$88 ﹤0.01% 1038
2016
Q4
$5K Hold
173
﹤0.01% 1012
2016
Q3
$4K Buy
173
+157
+981% +$3.63K ﹤0.01% 1035
2016
Q2
$0 Sell
16
-138
-90% ﹤0.01% 1363
2016
Q1
$4K Buy
154
+115
+295% +$2.99K ﹤0.01% 991
2015
Q4
$1K Buy
+39
New +$1K ﹤0.01% 1223